Phototherapy Equipment Market Analysis and Demand Forecast to 2022

The global phototherapy equipment market is witnessing considerable growth due to the increasing incidence of neonatal jaundice and increasing prevalence of skin problems including psoriasis, eczema and vitiligo. Moreover, the increasing adoption of LED-based phototherapy equipment and launch of technologically advanced products are further supporting the growth of the market. Among the various equipment types, the conventional phototherapy equipment segment lead the market in terms of size. The phototherapy equipment for treating skin diseases contributed largest revenue to the global market in 2015 and it is expected to grow at the fastest rate during the forecast period. Hospitals are the largest end user of these equipment as most of these treatments are performed in hospitals for increased patient safety.

Explore report at: https://www.psmarketresearch.com/market-analysis/phototherapy-equipment-market

Phototherapy is a light therapy, which involves exposing skin to ultraviolet light for a regular duration under the medical supervision for treating neonatal jaundice and treating psoriasis, and eczema globally. Phototherapy helps in reducing itching, increases vitamin D production, and calms inflammation.

The growing health care industry in emerging economies, development of low cost phototherapy equipment and increasing adoption of at home phototherapy treatment is creating ample revenue generation opportunities for the manufacturers of phototherapy equipment. However, high cost of these equipments and procedures and dearth of skilled professionals are the key factors hampering the growth of the global phototherapy equipment market.

Browse Other Related Report at: https://www.psmarketresearch.com/industry-report/medical-devices

The key players operating in the global phototherapy equipment market are Philips Lighting Holding B.V., GE Healthcare, Natus Medical Incorporated, Phoenix Medical Systems Pvt. Ltd., Atom Medical Corporation, National Biological Corporation, Solarc Systems Inc., The Daavlin Company, and Nice Neotech Medical Systems Pvt. Ltd.

Advertisements

Protein A Resin Market Size, Development, Growth and Demand Forecast to 2025

Protein A Resin Market

The global protein A resin market is expected to witness considerable growth during the forecast period due to the increasing research and development activities and increasing prevalence of chronic diseases. High traction for monoclonal antibodies in biopharmaceutical industry is supporting the growth of the global market. The increasing demand for monoclonal antibodies has fueled the need for high capacity commercial scale purification of monoclonal antibodies. Protein A resins are designed for the simple and rapid purification of antibodies. Therefore, an increase in demand for monoclonal antibodies implies an increase in demand for protein A resins. The market for natural protein A resin was the larger than recombinant protein A resin market in 2015; however, recombinant protein A resin market is expected to witness the higher growth during the forecast period. Among the different matrix of the protein A resin chromatography, agarose-based matrix was the largest contributor to the global protein A resin revenue in 2015. Biopharmaceutical industry was the largest end user of the protein A resins in 2015, as most monoclonal antibody research development activities are carried out in this industry.

Explore more about “Global Protein A Resin Market” at: https://www.psmarketresearch.com/market-analysis/protein-a-resin-market

The increasing compliance for low cost biosimilar antibodies in emerging economies, and increasing number of contract research organizations (CROs) in biopharmaceutical industry are expected to create ample revenue generation opportunities in the global protein A resin market. However, increasing traction for alternative antibody purification methods may hamper the growth of the global protein A resin market to some extent.

Request for Table of Content at: https://www.psmarketresearch.com/market-analysis/protein-a-resin-market/toc-sample

Geographically, North America accounted for the largest share in the global protein A resin market in 2015, owing to the large number of clinical trials for the monoclonal antibody based therapeutics and increasing traction for biosimilars with the recent U.S. Food and Drugs Administration in the region. The U.S. contributed largest revenue to the North American as well as global protein A resin market. The country is expected to remain the largest market for protein A resin globally during the forecast period.

The protein A resin market is expected to witness the highest growth in Asia-Pacific during the forecast period. The highest growth in the region is attributed to the increasing compliance for biosimilars and shifting global interest for expanding biopharmaceutical manufacturing capacities in the emerging economies of the region.

Browse Other Related Report at: https://www.psmarketresearch.com/industry-report/pharmaceuticals

The key players operating in the global protein A resin market are General Electric Company, Thermo Fisher Scientific Inc., Merck KGaA, Tosoh Corporation, Repligen Corporation, Novasep, Expedeon Ltd., and GenScript.

Hearing Aids Market Size, Share, Development and Forecast to 2020

Hearing Aids Market

The global hearing aids market is growing, due to technological advancement in the hearing aids, such as Bluetooth integrated hearing aid. During the forecast period, the hearing aid devices is expected to report larger share, among all the products of hearing aids, due to technological advancement and increasing regulatory approvals in the market. Behind-the-ear hearing aids segment dominate the hearing aids devices market; however the canal hearing aids are expected to grow at the highest rate in the forecasted period, due to increasing number of research and development initiatives. On the basis of type of hearing loss, sensorineural hearing loss segment led the market, due to increasing prevalence of hearing loss. Moreover, on the basis of end users the adults segment led the market, due to growing geriatric population.

Explore Report at: https://www.psmarketresearch.com/market-analysis/hearing-aids-market

The unexplored market in the hearing aids industry of the developing economies is creating abundant growth opportunities for the global market. Some of the major trends in the global market are growing product innovation, increasing number of collaborations and partnerships, and increasing number of mergers and acquisitions. Hearing aids are the devices and implants used for people suffering from hearing loss or impairment. Hearing aid devices are electronic devices, which amplify sound waves in order to help people hear sound. There are various types of hearing aids, such as receiver-in-the-ear (RITE) hearing aids, canal hearing aids, behind-the-ear (BTE) hearing aids, and in-the-ear (ITE) hearing aids. In addition, the cochlear implant helps deaf person to recognize and interpret various sounds, in order to improve the quality of life of a deaf person.

Some of the factors driving the growth of the global hearing aids market are growing geriatric population, increasing healthcare expenditure, and increasing prevalence of hearing loss. In addition, the increasing research and development for the innovative and advanced hearing aids, and increasing public awareness about hearing loss are also driving the growth of the market. However, the high cost of hearing aids and low penetration rate of devices are some of the factors, restraining the growth of the global hearing aids market. In addition, limited reimbursements, lack of primary healthcare facilities in developing countries are also inhibiting the growth of the global market.

Browse Related Market Research at: https://www.psmarketresearch.com/industry-report/medical-devices

Some of the companies operating in the global hearing aids market are William Demant Holding A/S, Zounds Hearing Inc., GN Store Nord A/S, Sonova Holding AG, Cochlear Limited, Widex, Sivantos Pte Ltd., Sebotek Hearing Systems LLC, and Starkey Hearing Technologies Inc.

Spirometer Market Analysis, Size, Growth and Demand Forecast to 2020

Spirometer Market

The global spirometer market is growing due to growing awareness about the advanced respiratory care therapeutic and monitoring devices, increasing home use of spirometers, and technological advancement in respiratory care devices. The diagnostic application dominates the application segment of the market, as it is mainly used for the diagnosis of various respiratory diseases. Based on products, the table-top spirometer segment led the market, as the device is compact in nature.  The unexplored market in the spirometer industry of the developing economies is creating ample growth opportunities for the global market.

Explore Report at: https://www.psmarketresearch.com/market-analysis/spirometer-market

Spirometer is an instrument used to assess lung function by measuring the volume of air inhaled and exhaled from the lungs after maximum inhalation by patient. It helps in the diagnosis of various respiratory diseases, such as chronic obstructive lung disease (COPD), asthma, bronchitis and emphysema, other conditions that affect breathing, and for screening in occupational environment. It is primarily used for the analysis of prognosis of the respiratory diseases, and analysis of lung function before surgery. Hand-held, table-top and desktop spirometers are the major type of spirometers. Table-top is extensively used in clinics and hospitals. Hand-held are easy to use and are used in homecare and general practice by smokers and asthma patients. Moreover, desktop spirometers are used especially for the diagnosis of black lungs, tuberculosis, chronic obstructive diseases and other respiratory diseases. It is reliable for pre/post- bronchodilator use, with reversible analysis and automatic interpretation. It is used to measure forced vital capacity, peak expiratory flow, slow vital capacity, forced expired volume in one second and others.

Browse Other Related Report at: https://www.psmarketresearch.com/industry-report/medical-devices

Some of the companies operating in the global spirometer market are Welch Allyn Inc., Schiller AG, Carefusion Corporation, NDD Medical Technologies Inc., Philips Healthcare, Cosmed, Midmark Corporation, Medical International Research, Futuremed, SDI Diagnostics, MGC Diagnostics Corporation, Nihon Kohden Corporation, Vitalograph, and Jones Medical Instrument Company.

Estrogen Receptor-Positive Breast Cancer Pipeline Analysis, 2017

The study analyzed that the estrogen receptor positive breast cancer pipeline comprises approximately 74 drug candidates, of which nine products are in Phase III, 16 products in Phase II, 18 products in Phase I, and three products are in Pre-Clinical stage. The development of 14 ER+ breast cancer drug candidates was found to be inactive, and 14 products were discontinued. ER+ breast cancer is the most common type of breast cancer diagnosed and refers to the cancer cells that have receptors on their surface to bind with estrogen. Breast cancer is a syndrome that affects the breast tissues. In breast cancer, cells in the breast grow in an uncontrollable manner and form tumor, which can be felt as a lump or can be viewed under x-ray. Invasion of new therapeutic agents, such as gene therapy, cell therapy and monoclonal antibodies are expected to provide an effective and concrete treatment for the disease, more in the light of the new technologies available.

Access Report Overview: https://www.psmarketresearch.com/market-analysis/estrogen-receptor-positive-breast-cancer-pipeline-analysis

Insights on pipeline analysis

As per the findings of the research, a major share of ER+ breast cancer pipeline drug candidates are being developed to be administered by oral route and rest by intravenous route and subcutaneous route. Most of the therapeutic candidates are being developed to be administered by oral route due to high patient compliance.

Several companies are developing ER+ breast cancer drug candidates in different phases. Novartis AG, Syndax Pharmaceuticals, Tesaro, Inc. and others have their ER+ breast cancer drug candidates in Phase III stage of development. Novartis AG has three drug candidates in Phase III stage and two drug candidates in Phase I clinical stage.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/estrogen-receptor-positive-breast-cancer-pipeline-analysis/report-sample

Major companies collaborate for the development of ER+ breast cancer pipeline

The research finds that different companies have collaborated for the development of ER+ breast cancer. In May 2015, Tesaro, Inc entered in a collaboration with Merck & Co. to evaluate the combination of Tesaro’s Niraparib plus Merck’s anti-PD1 therapy, Keytruda (pembrolizumab), in a Phase 1/2 clinical trial. Also, in January 2016, Radius Health, Inc. entered in a worldwide clinical collaboration with Novartis Pharmaceuticals to evaluate the safety and efficacy of combining investigational agent RAD1901 with LEE011 for advanced breast cancer.

Some of the key players developing drugs for Estrogen Receptor-Positive (ER+) breast cancer are Chipscreen Biosciences, Ltd., Eli Lilly & Company, Genentech, Inc., Novartis AG, Ipsen, Syndax Pharmaceuticals, Inc., Tesaro, Inc Astellas Pharma Inc., AstraZeneca plc, and Bayer AG.

Cranio Maxillofacial Implants Market Analysis, Size, Development and Forecast to 2020

Cranio Maxillofacial Implants Market

The global cranio maxillofacial implants market is growing, due to increasing frequency of fractures with the growth of aging population, who are more prone to fractures. Cranio maxillofacial implants surgery is performed for treating severe injuries in patient’s cranial and facial bones. The treatment of injured cranial and facial bones require internal fixators, such as plate and screw fixation systems, bone graft substitutes flap fixation devices, or others to fix the facial fracture. In addition, globally the emergence of new procedural techniques and positive clinical outcome is further fuelling the growth of the market.

Explore more about “Global Cranio Maxillofacial Implants Market” at: https://www.psmarketresearch.com/market-analysis/cranio-maxillofacial-implants-market

The internal fixators have reduced the hospital stays, the incidence of improper healing, and improper positioning of broken bones. These fixators are durable as they are made up of stainless steel and titanium. External fixation is used as temporary treatment for fractures, as they can be applied easily and doesn’t require long surgery to fix fractures. The increase in number of collaborations and partnerships and shifting of internal fixators from metallic to non-metallic, bio-absorbable material are the major trends witnessed in the global market.

Download TOC at: https://www.psmarketresearch.com/market-analysis/cranio-maxillofacial-implants-market/toc-sample

Geographically, North America holds the major share in the global market for cranio maxillofacial implants, due to the growth of aging population. In addition, the increasing healthcare expenditure and growth of sports injuries, and injuries related to cranial and facial bones also leads to the growth of the market in the region. The Asian market is expected to grow with a higher rate, with Japan, China and India, being the fastest growing markets in the region. The key growth driving factors of the cranio maxillofacial implants market in the developing countries are increasing road accidents, growing sports injuries, and increasing aging population.

Some of the major companies operating in the global cranio maxillofacial implants market are Stryker Corporation, Johnson & Johnson Services Inc., B. Braun Melsungen AG, Zimmer Holding Inc., Medtronic Inc. and CONMED.

Neuroprosthetics Market Development, Growth and Forecast to 2020

Neuroprosthetics Market

The global neuroprosthetics market is growing due to early commercialization of pipeline products and innovative self charging neural implants in the industry. The self-charging neural implant reduces the need for costly and risky surgery, in order to replace discharge battery and controlling machinery. The motor prosthetic, a type of neuroprosthetics dominates the market. The visual neuroprosthetics segment is expected to grow with the fastest rate. The Parkinson’s disease segment is expected to grow with the fastest rate in the coming years.

Explore more about “Global Neuroprosthetics Market” at: https://www.psmarketresearch.com/market-analysis/neuroprosthetics-market

Some of the factors driving the growth of the global neuroprosthetics market are growing geriatric population, increasing prevalence of neurological disorders such as Parkinson’s disease, stroke and brain injury, increasing healthcare expenditure, increasing government and government association’s support and initiatives, and improving healthcare infrastructure. In addition, the rapid progression of devices, increasing healthcare awareness, high availability of funds for R&D of neuroprosthetics and new device approvals are also contributing to growth of the global neuroprosthetic market. However, the high cost of therapy and products, limited reimbursement, and side effects of neuroprosthetics are some of the factors, restraining the growth of the global neuroprosthetics market. Moreover, the stringent regulatory requirement and limited compatibility with MRI, ultrasound and x-ray devices are also inhibiting the growth of the global neuroprosthetic market.

Download TOC at: https://www.psmarketresearch.com/market-analysis/neuroprosthetics-market/toc-sample

Some of the companies operating in the global neuroprosthetics market are Boston Scientific Corporation, Cyberonics Inc., Cochlear Limited, NDI Medical LLC, Nervo Corporation, NeuroPace Inc., Medtronic Inc., Aleva Neuroprosthetic, Oticon Medical, St Jude Medical, Retina Implant AG, and Sonova Group.

UK Cards and Payments Market Analysis, Size, Development and Forecast to 2020

cards-and-payments-market

The research report provides in depth analysis and insights into the UK Cards and Payments Market including, strategies deployed by banks to market debit and credit cards and competitive landscape (card issuers in the country) for both debit cards and credit cards. The study includes 3 years historical market size and 6 years market forecast in terms of number of cards, value and volume of transactions processed through these cards, and other key metrics. The report also provides information on the key industry trends, major schemes, banks and detailed segmentation of card and payment industry. The research report is a new offering from the company’s Financial Services domain, and leveraged from the company’s existing cards and payments database of 50+ countries.

Explore Report with Detailed TOC onUK Cards and Payments Market” at: https://www.psmarketresearch.com/market-analysis/uk-cards-and-payments-market

In terms of number of cards in circulation, the UK payment cards market grew at a CAGR of 2% during the period 2012-2014. The growth in GDP per capita of the country is expected to increase the cards usage over the forecast period. The GDP per capita increased during the period 2012–2014, from GBP 25,986.1 in 2012 to GBP 27,778.1 in 2014 and is likely to reach GBP 34,090.6 by 2020. Also, the UK population grew steadily from 63.7 million in 2012 to 64.5 million in 2014, and is expected to reach 67.1 million by 2020. This increase in population is expected to encourage the card spending over the forecast period. Consumer preference for cashless payments allows growth of card payments.

In UK, the debit cards dominate the payment cards market in terms of number of cards in circulation. The debit cards accounted for 62% of the total number of cards in circulation in 2014. Debit cards are being used by consumers to shop at retail outlets, withdraw cash from ATMs and make online payments. Key players in the debit card market included Lloyds Bank, Barclays Bank, HSBC, Santander, and Nationwide. The debit card market in the country is very concentrated in terms of number of cards in circulation, with five major banks accounting for 79% share of the total cards in 2014.

Browse Other Related Report at: https://www.psmarketresearch.com/industry-report/cards-and-payments

Charge cards segment represents a small portion of the UK pay later card market but is expected to gain momentum due to expected growth in the volume of high net worth individuals (HNIs) during the period 2015–2020. The frequency of charge card use increased at a CAGR of 5.6% during 2012-2014. The frequency of transaction is expected to reach up to 75 times by 2020.